| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/18/2007 | USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271262 Antiproliferative agents |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271242 Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 09/18/2007 | US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 09/18/2007 | US7271182 Salts of benzimidazole compound and use thereof |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271175 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 09/18/2007 | US7271174 Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | US7271167 Compounds, compositions, and methods |
| 09/18/2007 | US7271161 Platinum complexes as antitumor agents in combination with biochemical modulation |
| 09/18/2007 | US7271160 Firt and second hsp(heat shock protein)-binding moieties joined by a linker, which bind to the pocket of hsp90 with which ansamycin antibiotics bind; linked geldanamycin, for example; treating cancer |
| 09/18/2007 | US7271159 Camptothecin analogs and methods of preparation thereof |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | US7270960 Diagnosis of ovarian carcinomas |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | US7270812 Pharmaceutical composition for treatment of cancers |
| 09/18/2007 | US7270808 Having covalently coupled bioactive agent and targeting ligand; controlled release; stability, solubility; reduced toxicity |
| 09/18/2007 | CA2365359C Medicaments containing a sulfopyranosylglycerol derivative |
| 09/18/2007 | CA2331803C Culture of sessile marine animals |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2323809C A method for chemoprevention of prostate cancer |
| 09/18/2007 | CA2297832C Pellet-type formulation intended for treating the intestinal tract |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2176719C Fatty acid delivery system |
| 09/18/2007 | CA2168656C A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/16/2007 | CA2581960A1 Iap bir domain binding compounds |
| 09/13/2007 | WO2007103816A2 Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selection |
| 09/13/2007 | WO2007103427A2 Medical use of bilirubin and its structural analogues |
| 09/13/2007 | WO2007102769A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102768A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them . |
| 09/13/2007 | WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102525A1 Methods for damaging cells using effector functions of anti-cdh3 antibodies |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007102383A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 09/13/2007 | WO2007102375A1 METHOD FOR PRODUCING MgFe2O4 TO BE USED AS LIVING ORGANISM HEATING MATERIAL AND MgFe2O4 OBTAINED BY SUCH PRODUCTION METHOD |
| 09/13/2007 | WO2007102368A1 Novel 3-(1-aminoalkylidene)furan-2,4(3h,5h)-dione derivative, method for producing the same, and pharmaceutical composition containing the same as active ingredient |
| 09/13/2007 | WO2007102069A1 Improved prodrugs of cc-1065 analogs |
| 09/13/2007 | WO2007101997A1 Ruthenium (ii) compounds |
| 09/13/2007 | WO2007101988A2 Use of tsg-6 for treating bone diseases |
| 09/13/2007 | WO2007101873A2 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer |
| 09/13/2007 | WO2007101782A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007101332A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | WO2007101331A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007087419A3 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| 09/13/2007 | WO2007087283A3 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 09/13/2007 | WO2007087026A3 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 09/13/2007 | WO2007086932A3 Prostate stem cell antigen vaccines and uses thereof |
| 09/13/2007 | WO2007082208A3 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 09/13/2007 | WO2007075307A3 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate |
| 09/13/2007 | WO2007067991A3 Human monoclonal antibodies to o8e |
| 09/13/2007 | WO2007059143A3 Methods of identifying and treating individuals exhibiting mdr-1 overexpression with protein tyrosine kinase inhibitors and combinations thereof |
| 09/13/2007 | WO2007042309A3 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 09/13/2007 | WO2007036945A3 Hepatocyte growth factor receptor splice variants and methods of using same |
| 09/13/2007 | WO2007034527A3 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF |
| 09/13/2007 | WO2007030780A3 Quinoline derivatives and use as antitumor agents |
| 09/13/2007 | WO2007022511A3 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 09/13/2007 | WO2006096487A3 Methods and compositions for modulating tweak and fn14 activity |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070213546 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213382 2-methylthiazolidine-2, 4-dicarboxylic acid-containing combination preparations |
| 09/13/2007 | US20070213380 Thiadiazoline derivative |
| 09/13/2007 | US20070213374 Malonamide Derivatives |
| 09/13/2007 | US20070213353 Esters in position 20 of camptothecins |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213328 Pyridothiophene Compounds |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212346 Highly Concentrated Stabilized Igm Solution |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | CA2645137A1 Heterobicyclic pyrazole compounds and methods of use |
| 09/13/2007 | CA2644782A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | CA2644774A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | CA2643790A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 09/13/2007 | CA2643685A1 Ruthenium (ii) compounds |
| 09/13/2007 | CA2643363A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
| 09/13/2007 | CA2642870A1 Improved prodrugs of cc-1065 analogs |
| 09/12/2007 | EP1832663A2 Uses of DNA-PK |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832605A1 Neural cell adhesion molecule (NCAM) binding antibodies |
| 09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832589A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto |